復(fù)方沙棘籽油栓治療宮頸HPV感染的療效分析
[Abstract]:Objective: to investigate the effect of compound Hippophae rhamnoides seed oil suppository on the outcome of drug therapy for cervical HPV infection. Methods: from December 2012 to December 2013, 169 patients with high-risk HPV of cervical infection were selected from the Department of Oncology and Gynecology, first Hospital of Jilin University. They were randomly divided into treatment group (n = 91) and control group (n = 78). The treatment group was treated with compound seabuckthorn seed oil suppository for 3 months, while the control group was not treated with drugs. TCT and HPV were performed in both groups after 3 months. Sexual life and use of other drugs are prohibited during the trial. Results: 1. The total effective rate of the treatment group was 74.73% (68 / 91), while the total effective rate of the control group was 62.82% (49 / 78). The total effective rate of the treatment group was higher than that of the control group (p0.05). The age of 91 patients in the treatment group was 21-59 years old (mean (39.57 鹵8.54) years), and that in the control group was 21-60 years old (mean (40.01 鹵9.93) years, p0.05). The total effective rate was 87.75% (43 / 49) in the treatment group, 7 cases in the middle load group, 69.23% (18 / 26) in the middle load group, and 2 cases in 5 cases in the high load group. The total effective rate was 87.75% (43 / 49) in 27 patients in the treatment group, and 69.23% (18 / 26) in the middle load group, the total effective rate was 87.75% (43 / 49). The total effective rate was 43.75% (7 / 16). Conclusion: 1. Compound Hippophae rhamnoides seed oil suppository is effective in the treatment of high-risk HPV infection in cervix, and its curative effect tends to decrease with the increase of host virus load. Combined with TCT or colposcopy results, the outcome of the disease needs to be evaluated synthetically. 2. If high-risk HPV is positive, clinical intervention should be carried out as soon as possible, regardless of viral load.
【學(xué)位授予單位】:吉林大學(xué)
【學(xué)位級別】:碩士
【學(xué)位授予年份】:2014
【分類號】:R737.33
【參考文獻(xiàn)】
相關(guān)期刊論文 前10條
1 龐天云;胡新榮;戴世忠;;人乳頭狀瘤病毒引起宮頸腫瘤的病理過程及其機制[J];廣東醫(yī)學(xué)院學(xué)報;2007年01期
2 王琦,周玲仙,羅曉東;苦木科植物化學(xué)成分及生物活性研究進(jìn)展[J];國外醫(yī)學(xué)(中醫(yī)中藥分冊);2004年05期
3 肖志明;沈守榮;連平;王曉艷;劉芬;;裸鼠脾臟移植瘤模型在NGX6抗結(jié)腸癌轉(zhuǎn)移作用研究中的應(yīng)用[J];中南大學(xué)學(xué)報(醫(yī)學(xué)版);2007年05期
4 張培珍,郭草,丁小凡,毛利娜,李蘭萍;沙棘油對小鼠移植性S-(180)的抑制作用及其對免疫器官重量的影響[J];生理科學(xué);1987年06期
5 孫海艷;袁亞敏;魏紹斌;;HPV感染與宮頸癌的預(yù)防[J];江西中醫(yī)藥;2006年09期
6 鎖丙榮;;電子陰道鏡(EC)檢查和HPV-DNA檢測用于診斷宮頸人乳頭瘤病毒亞臨床感染(SPI)的臨床價值分析[J];中國美容醫(yī)學(xué);2012年12期
7 王長青;肖強;;轉(zhuǎn)錄因子E2F-1的研究進(jìn)展[J];中華腫瘤防治雜志;2011年04期
8 楊春蕾,王正榮,王浴生;異鼠李素誘導(dǎo)腫瘤細(xì)胞凋亡[J];四川生理科學(xué)雜志;2003年04期
9 馮余寬,彭秀瓊,朱聯(lián),梅蓉,劉珊玲;奧平栓治療女性生殖道HPV亞臨床感染的臨床試驗研究[J];實用婦產(chǎn)科雜志;2003年04期
10 李超荊,徐亞銘,孫月麗,歸綏琪,瞿霞仙,丁聲頌,伍q賢,樓賢鴻,劉星X&,林云福;掌葉半夏抗子宮頸癌成份的研究 Ⅱ.β-谷甾醇的分離、鑒定及療效觀察[J];上海第一醫(yī)學(xué)院學(xué)報;1981年06期
本文編號:2133244
本文鏈接:http://sikaile.net/yixuelunwen/fuchankeerkelunwen/2133244.html